Brief: Creo Medical Says Tracking On Plan For 40% To 60% Revenue Growth For FY
21/07/2025 07:28
July 21 (Reuters) - Creo Medical Group PLC CREO.L: CREO MEDICAL H1 ADJUSTED EBIT GBP -6.9 MILLION CREO MEDICAL GROUP : TRACKING ON PLAN FOR 40% TO 60% REVENUE GROWTH FOR FULL YEAR, IN-LINE WITH PRIOR GUIDANCE Source text: ID:nRSU7929Ra Further company coverage: CREO.L ((Reuters.Briefs@thomsonreuters.com;))